Staining was measured at superficial and deep sites for each melanocytic lesion.
Error bars represent the 10th and 90th percentiles. p values represent the significance of a trend test using Jonckheere-Terpstra trend test for the independent series (D) and the Page L trend test for the matched series (E) . N, nevi; P, primary melanoma; PM, metastatic primary melanoma; M, metastases. PS, superficial areas in primary melanomas; PD, deep areas in primary melanomas; MC, cortical metastatic deposits in lymph nodes; MM, metastatic deposits in medullary areas.
Note opposing gradients of ZEB2 and SNAIL2 versus ZEB1 and TWIST1 expression within the lesions. 
SUPPLEMENTAL EXPERIMENTAL PROCEDURES

Constructs and cell lines
Lentiviral vector encoding BRAF V600E (Denoyelle et al., 2006) and retroviral vector encoding a fusion protein consisting of BRAF linked to the T1 form of the human estrogen receptor hormone-binding domain (Pritchard et al., 1995) were selected in presence of puromycin (1.5 µg/ml), neomycin (100 g/ml) or hygromycin (25 g/ml) (all from Invitrogen).
siRNA
Transfections of siRNA were performed by electroporation with a single pulse of 250 V and 250 Fd by using the Gene Pulser Xcell electroporation system (Bio-Rad, Hercules, CA, USA).
List of siRNAs used for transient transfections: and puromycin (1.5 µg/ml). Plates were incubated for 2-3 weeks at 37°C. Colonies were stained with crystal violet (1 mg/ml Sigma-Aldrich) and counted under microscope.
Transwell invasion assays
Melan-a/BRAF-ER cells infected with retroviral vectors expressing EMT-TFs, or MM cells with transiently depleted EMT-TFs with siRNAs (48 hours post-transfection)
were seeded on matrigel-coated porous membranes (pore size, 8 μm; BD Biosciences) in transwells. Cells were allowed to invade matrigel towards FBS gradients for 24 hours. Cells that did not migrate were removed using a cotton swab.
The membranes were then fixed with methanol and stained with Gurr rapid staining kit (BDH). The number of invaded cells was determined by counting ten random fields using an inverted Nikon TE2000-U microscope.
Immunoblot analysis
Cells were washed twice with phosphate buffered saline (PBS) containing CaCl 2 and then lysed in a 100 mM NaCl, 1% NP40, 0.1% SDS, 50 mM Tris pH 8 RIPA buffer 
Quantitative analysis of immunostaining
Positive staining was scored via the H-score (Kinsel et al., 1989) , and three observers agreed the criteria for levels of positive staining. Four representative dermal fields were assessed; two from the superficial tumor close to the epidermal basal lamina in the papillary dermis and two from the deepest tumor sites within the reticular dermis, and a mean H-Score was calculated for both the superficial and deep sites. Superficial and deep sites of the metastatic lesions were also scored using the same criteria. Inter-observer agreement was measured using 12 randomly selected cases and an intra-class correlation coefficient (ICC) indicated high agreement (ICC = 0.92).
5'-RACE (Rapid amplification of cDNA ends)
ZEB2 and ZEB1 transcription start sites were identified using RACE kit (Roche) according to the manufacturer's protocol. Total RNA was isolated from A375P cells treated or mock treated with 10 µM U0126 for 24 h and used for the synthesis of the first strand cDNA using the SP2 primer complementary to the exon E2 of ZEB2 or ZEB1. After purification, terminal deoxynucleotidyl transferase was used to add dA tail to 3'-end of cDNA. cDNA was amplified using the oligo-dT anchor primer and ZEB2-or ZEB1-specific primer pairs (ZEB2, TGTTGTGCCAGGGGTGTTCCAC and ACAATTCAGGAAAGATTTTTGTCATGG; ZEB1,
GTCTGGTCTGTTGGCAGGTCATCC and TCCTCTGGTACACCTTCACAGTCAGC).
Amplified DNA was analyzed in agarose gels. For ZEB2, DNA was gel-purified, cloned, and the sequence of 20 recombinant plasmid DNAs was determined.
Chromatin immunoprecipitation
Chromatin purification and precipitation was performed following manufacturer's protocols (Active Motif, Rixensart, Belgium). For each chromatin preparation, cells grown in a 70% confluent 15 cm plate were fixed with 1% formalin for 5 min at room temperature. Fixation was stopped by an excess of glycine; nuclei from collected cells were extracted using a Dounce homogenizer and precipitated by brief centrifugation. Chromatin was sheared using sonication with one quarter setting (25 seconds for 4 times on ice). Sheared chromatin was used for each precipitation or Proteinase-K, the sample was used for PCR amplifications using EMT-TF genespecific or control primer pairs encompassing the AP-1 binding sequence elements.
GAPDH control primers were from Active Motif).
List of primer pairs used for ChIP
Luciferase reporter assays Cells were transiently transfected with luciferase reporter vectors along with the -galactosidase expression vector, pCMV-gal (Invitrogen). Forty-eight hours post-transfection, cells were harvested, lysed; and the luciferase activity was measured with a Lumat LB9501 tube luminometer (Berthold). -galactosidase activity was determined and used for the normalization of luciferase data.
Microarray processing and analysis BRAF-ER-melan-a cells expressing TWIST1, ZEB1, SNAIL2, or ZEB2 were treated with 4-OHT for 1 week before isolation of total RNA. Microarray processing and data analysis were performed on the ProfileXpert core facility (Bron, France). Total RNA (100 ng) was amplified and biotin-labeled using Kit GeneChip 3' IVT Express and procedures from Affymetrix (Santa Clara, CA, USA, http://www.affymetrix.com).
Microarrays analyses were performed using high-density oligonucleotide arrays (Mouse Genome 430 2.0 Array, Affymetrix). Fifteen μg of biotinylated cRNA were fragmented, and hybridization on chip was performed following Affymetrix protocol.
Arrays were washed and stained with streptavidin-phycoerythrin using GeneChip summarized and normalized using RMA, and significant differential expression was determined by a moderated t-test (Limma) using a fold change cutoff of 2.
Transcriptional expression analysis
Total RNA was isolated using Trizol reagent (Sigma-Aldrich) and reverse transcribed using a high cDNA capacity reverse transcription kit (Invitrogen) following the manufacturer's instructions. Real-time PCR intron-spanning assays were designed using the ProbeFinder software (Roche 
